TI
BIOS

Telemetry Investments’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Telemetry Investments’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$685K Hold
66,607
– – 1.08% 23
2022
Q3 		$667K Hold
66,607
– – 0.85% 35
2022
Q2 		$669K Hold
66,607
– – 0.79% 33
2022
Q1 		$658K Buy
+66,607
New +$657K 1.04% 37

Other funds holding BIOS

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
SV
Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return

Telemetry Investments's BIOS Position: Q4 2022 in Review

Telemetry Investments held its BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) position steady in Q4 2022 at 66,607 shares worth $685K. The position accounts for 1.08% of the portfolio, ranked #23.

Telemetry Investments first reported a position in BIOS in Q1 2022 and has held it in 4 quarters since. 67 funds tracked by Wall St. Rank hold BIOS as of Q4 2022.

  • Telemetry Investments held 66,607 shares of BioPlus Acquisition Corp. Class A Ordinary Shares worth $685K as of Q4 2022.
  • Telemetry Investments left its BioPlus Acquisition Corp. Class A Ordinary Shares share count unchanged in Q4 2022.
  • BioPlus Acquisition Corp. Class A Ordinary Shares made up 1.08% of Telemetry Investments's portfolio in Q4 2022, its #23 holding.
  • Telemetry Investments first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and has held it in 4 quarters since.
  • 67 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.